The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs & Medical Devices Avandia Research Center

FDA Warning, 5.22.07

in this section: Firm's Press Release, 10.1.07 | Another FDA Warning? 10.24.07 | avandia drug warning | Study Reveals Risks, 6.6.07 | FDA Warning, 5.22.07 | Secret Avandia Vote | Veterans Affairs: Avandia | FDA Approval of Avandia | NEJM Study | Warning Letter, 2001 | Sales Plunge | NEJM Update, 6.5.07 | FDA Safety Information | FDA Warning, 6.6.07 | Scientists Silenced | Dallas Lawsuit | Patients Switch Meds | Avandia Prescriptions Fall | Updated Study, 7.12.07 | Avandia Panel, 7.25.07 | Second Black Box? | Senators Testify | Experts Cite Risks | Black Box Warning | 9.12.07 Study Analysis | Actos Study | Arkansas Lawsuit | Weakens Bones | JAMA Report, 12.7.07 | Avandia Diabetes Pills | Avandia Warning


Bookmark This Page Print This Page Email This Page

FDA Alert on the Anti-Diabetes Drug Avandia:
Risk of Heart Attack

The U.S. Food and Drug Administration (FDA) has issued a warning regarding Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Data from clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.

The FDA recommends that people who are prescribed Avandia, especially those who are known to have underlying heart disease or who are at high risk of heart attack, should discuss with a medical profession this new warning as they weigh the treatment options for their type 2 diabetes.

The FDA also stresses that there is an inherent risk to switching patients with diabetes from one treatment to another even in the absence of specific risks associated with particular treatments.

Avandia is manufactured by GlaxoSmithKline, which is based in Research Triangle Park, N.C.

If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney. Get a free case review by filling out the form below.

Click To Talk To Us Online

Please complete the following questionnaire:

When did you start taking Avandia?
What cardiovascular problems did you experience with the drug?
What was the date you experienced cardiac complications?
Did you have any cardiovascular disease before taking Avandia?
Do you smoke?
How did you learn of Weitz & Luxenberg?
Contact Name
Email Address
Phone Number (optional)


see also:

Updated Study, 7.12.07 Latest News on Avandia: German Study Adds More Reasons to Avoid it
Latest Study in the News: Avandia May Worsen Complications of Diabetes

NEJM Study New England Journal of Medicine on Rosiglitazone (Avandia) Medication
Study on Rosiglitazone (Avandia) Medication and Risk of Cardiac Issues

News & Warnings Avandia Breaking News: Glaxo Warned in 2001 about Misleading Marketing
Bloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims